Recent News View all news Sep 17, 2024 Cinven to sell minority stake in SYNLAB to strategic investor Labcorp Read more » Sep 16, 2024 LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 Read more » Sep 16, 2024 Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health Read more » Sep 09, 2024 Labcorp to Acquire Select Outreach Services from Ballad Health Read more » Events View all events Sep 10, 2024 at 3:10 PM EDT Labcorp Holdings at the Baird 2024 Global Healthcare Conference Click Here for Webcast Aug 1, 2024 at 9:00 AM EDT Q2 2024 Labcorp Holdings Earnings Conference Call Click Here for Webcast Jun 4, 2024 at 2:00 PM CDT 44th Annual William Blair Growth Stock Conference Click Here for Webcast Financial Documents Current and historical annual reports and proxy statements View Documents SEC Filings View Labcorp’s annual filings, current reports and historic filings View Reports Corporate Governance Corporate management, board of directors and committee overview Learn moreabout corporate governance News & Events Press releases, news and events for investors News and Events Stock & Fundamentals Labcorp trading statistics, balance sheets, cash flow and income statements Fundamentals Contacts Investor Relations contact information Contact Information